Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Debt Ratio (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Debt Ratio for 5 consecutive years, with 0.54 as the latest value for Q1 2026.

  • For Q1 2026, Debt Ratio fell 22.35% year-over-year to 0.54; the TTM value through Mar 2026 reached 0.54, down 22.35%, while the annual FY2025 figure was 0.81, 51.55% up from the prior year.
  • Debt Ratio hit 0.54 in Q1 2026 for Phathom Pharmaceuticals, down from 0.81 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.86 in Q3 2025 and bottomed at 0.33 in Q4 2023.
  • Average Debt Ratio over 5 years is 0.56, with a median of 0.54 recorded in 2026.
  • Year-over-year, Debt Ratio crashed 42.38% in 2023 and then skyrocketed 89.82% in 2025.
  • Phathom Pharmaceuticals' Debt Ratio stood at 0.58 in 2022, then plummeted by 42.38% to 0.33 in 2023, then soared by 59.84% to 0.53 in 2024, then soared by 51.55% to 0.81 in 2025, then tumbled by 33.51% to 0.54 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.54, 0.81, and 0.86 for Q1 2026, Q4 2025, and Q3 2025 respectively.